Monopar Therapeutics (NASDAQ:MNPR) Coverage Initiated at Chardan Capital
Chardan Capital initiated coverage on shares of Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) in a report released on Monday, Marketbeat.com reports. The firm set a “buy” rating and a $60.00 price target on the stock. Chardan Capital’s target price suggests a potential upside of 80.18% from the stock’s previous close. Several other equities analysts […]
Chardan Capital initiated coverage on shares of Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) in a report released on Monday, Marketbeat.com reports. The firm set a “buy” rating and a $60.00 price target on the stock. Chardan Capital’s target price suggests a potential upside of 80.18% from the stock’s previous close. Several other equities analysts […]
